| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/03/2011 | WO2010137873A9 Primer for the diagnosis of the new influenza a virus, probe, kit comprising same, and diagnosis method using the kit |
| 06/03/2011 | WO2010129485A3 Compositions and methods for identifying enzyme and transport protein inhibitors |
| 06/03/2011 | CA2782211A1 Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection |
| 06/03/2011 | CA2782026A1 Pharmaceutical composition comprising mirna-100 and its use in the modulation of blood vessel growth and endothelial inflammation |
| 06/03/2011 | CA2782014A1 Optimized endonucleases and uses thereof |
| 06/03/2011 | CA2781835A1 Chimeric endonucleases and uses thereof |
| 06/03/2011 | CA2781693A1 Chimeric endonucleases and uses thereof |
| 06/03/2011 | CA2781654A1 Novel genomic biomarkers for irritable bowel syndrome diagnosis |
| 06/03/2011 | CA2781622A1 Detection of aad-12 soybean event 416 |
| 06/03/2011 | CA2781618A1 Minor groove binder (mgb)-oligonucleotide mirna antagonists |
| 06/03/2011 | CA2781559A1 Novel fatty acid elongase and uses thereof |
| 06/03/2011 | CA2781399A1 Recombinant thermoascus aurantiacus beta-glucosidase variants for production of fermentable sugars from cellulosic biomass |
| 06/03/2011 | CA2781375A1 Aad-12 event 416, related transgenic soybean lines, and event-specific identification thereof |
| 06/03/2011 | CA2781131A1 Methods of increasing dihydroxy acid dehydratase activity to improve production of fuels, chemicals, and amino acids |
| 06/03/2011 | CA2780956A1 Novel fatty acid desaturase and uses thereof |
| 06/03/2011 | CA2779353A1 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi)-anchors |
| 06/03/2011 | CA2778714A1 Targeted binding agents against b7-h1 |
| 06/03/2011 | CA2776568A1 Sirna compounds comprising terminal substitutions |
| 06/03/2011 | CA2776513A1 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume |
| 06/02/2011 | US20110131687 Polypeptides having arabinofuranosidase activity and polynucleotides encoding same |
| 06/02/2011 | US20110131686 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 06/02/2011 | US20110131685 Method for Improving Transformation Efficiency Using Powder |
| 06/02/2011 | US20110131684 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
| 06/02/2011 | US20110131682 Means and Methods for Controlling Flowering in Plants |
| 06/02/2011 | US20110131681 Increased Stress Tolerance, Yield, and Quality via Glutaredoxin Overexpression |
| 06/02/2011 | US20110131680 Method of enhancing gene expression in plants |
| 06/02/2011 | US20110131679 Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
| 06/02/2011 | US20110131678 Compositions and methods for differential regulation of fatty acid unsaturation in membrane lipids and seed oil |
| 06/02/2011 | US20110131676 Soybean Cultivar S080104 |
| 06/02/2011 | US20110131675 Soybean Cultivar S080103 |
| 06/02/2011 | US20110131674 Soybean Cultivar S080102 |
| 06/02/2011 | US20110131673 Soybean Cultivar S080195 |
| 06/02/2011 | US20110131672 Stress resistant plants |
| 06/02/2011 | US20110131671 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 06/02/2011 | US20110131670 Non-Aggregating Fluorescent Proteins and Methods for Using the Same |
| 06/02/2011 | US20110131668 Improved gene silencing methods |
| 06/02/2011 | US20110130710 Treatment of abnormal or excessive scars |
| 06/02/2011 | US20110130443 Compositions And Methods For Inhibiting Expression Of Factor V Leiden Mutant Gene |
| 06/02/2011 | US20110130442 Nucleic acid capable of controlling degranulation of mast cell |
| 06/02/2011 | US20110130440 Non-natural ribonucleotides, and methods of use thereof |
| 06/02/2011 | US20110130347 Identification of new splice-variants of g-protein coupled receptor ep3 and uses thereof |
| 06/02/2011 | US20110130329 Glp-1 Fusion Peptides, Their Production and Use |
| 06/02/2011 | US20110130319 Subtilases |
| 06/02/2011 | US20110130304 Method for creating a viral genomic library, a viral genomic library and a kit for creating the same |
| 06/02/2011 | US20110130301 Settings for recombinant adenoviral-based vaccines |
| 06/02/2011 | US20110130287 Tubulin regulatory elements for use in plants |
| 06/02/2011 | US20110129928 Method of Manufacturing Induced Pluripotent Stem Cell Originated from Somatic Cell |
| 06/02/2011 | US20110129927 Chinese hamster apoptosis-related genes |
| 06/02/2011 | US20110129885 Microorganism for the production of succinic acid |
| 06/02/2011 | US20110129883 Inactivation of genes of the mep pathway |
| 06/02/2011 | US20110129882 Gene coding for glucose-6-phosphate-dehydrogenase proteins |
| 06/02/2011 | US20110129875 Immunosupprressive polypeptides and nucleic acids |
| 06/02/2011 | US20110129874 Pichia Pastoris Das Promoter Variants |
| 06/02/2011 | US20110129873 Recombinant DNA Vectors for Expression of Human Prolactin Antagonists |
| 06/02/2011 | US20110129868 Cell capable of replicating novel hcv replicon, cell capable of replicating full-length hcv rna, and use of those cells |
| 06/02/2011 | US20110129867 Compound Screening Using Chondrocytes |
| 06/02/2011 | US20110129855 Recombinant Anti-Epidermal Growth Factor Receptor Antibody Compositions |
| 06/02/2011 | US20110129852 Organic compounds |
| 06/02/2011 | US20110129828 Specific double-stranded probes for homogeneous detection of nucleic acid and their application methods |
| 06/02/2011 | US20110129586 White wheat varieties, and compositions and methods of using the same |
| 06/02/2011 | US20110129566 Functional Enhancement of Yeast to Minimize Production of Ethyl Carbamate Via Modified Transporter Expression |
| 06/02/2011 | US20110129534 Reduction of dermal scarring |
| 06/02/2011 | US20110129527 Rab3b for the treatment and prevention of parkinson's disease |
| 06/02/2011 | US20110129511 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 06/02/2011 | US20110129502 Immunogenic Constructs |
| 06/02/2011 | US20110129499 Dual delivery system for heterologous antigens |
| 06/02/2011 | US20110129498 Vaccine for the prevention and therapy of hcv infections |
| 06/02/2011 | US20110129493 Combined measles-human papilloma vacine |
| 06/02/2011 | US20110129490 Modulation of production of retroviruses by apobec4 |
| 06/02/2011 | US20110129487 Plasmic production and expression of recombinant proteins in cells grown without antibiotics |
| 06/02/2011 | US20110129485 Modified Galectin-2 and Uses Thereof |
| 06/02/2011 | US20110129483 Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy |
| 06/02/2011 | US20110129482 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 06/02/2011 | US20110129481 Antibody specifically binding to c-Met and methods of use |
| 06/02/2011 | US20110129480 Anti-ferroportin 1 monoclonal antibodies and uses thereof |
| 06/02/2011 | US20110129478 Pharmaceutical composition for treatment and prevention of cancer |
| 06/02/2011 | US20110129477 NOGO Receptor Homologs |
| 06/02/2011 | US20110129476 Mzb1, a novel b cell factor, and uses thereof |
| 06/02/2011 | US20110129475 Basb 205 polypeptides and polynucleotides from haemophilus influenzae |
| 06/02/2011 | US20110129474 Methods And Systems For Multi-Antibody Therapies |
| 06/02/2011 | US20110129470 Use of specifically engineered enzymes to enhance the efficacy of prodrugs |
| 06/02/2011 | US20110129465 Mammalian Receptor Proteins; Related Reagents and Methods |
| 06/02/2011 | US20110129464 Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies |
| 06/02/2011 | US20110129461 Mat II Beta Subunit RNAi and Therapeutic Methods Using Same |
| 06/02/2011 | US20110129457 Variant hhip1 protein and methods and uses thereof |
| 06/02/2011 | US20110129450 Method of promoting neurogenesis by modulating secretase activities |
| 06/02/2011 | US20110129414 Single Chain Fragment of Monoclonal Antibody 9B9 and Uses Thereof |
| 06/02/2011 | US20110129412 Antibodies Directed to CD20 and Uses Thereof |
| 06/01/2011 | EP2327985A2 T1R Hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 06/01/2011 | EP2327799A1 Method for quantification or detection of dna |
| 06/01/2011 | EP2327798A1 MicroRNAs and uses thereof |
| 06/01/2011 | EP2327797A1 Method of nucleic acid sequencing |
| 06/01/2011 | EP2327794A2 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 06/01/2011 | EP2327788A1 Conditional expression of transgenes in vivo |
| 06/01/2011 | EP2327787A1 Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences |
| 06/01/2011 | EP2327786A2 Site-specific serine recombinases and methods of their use |
| 06/01/2011 | EP2327785A2 EPSP synthase domains conferring glyphosate resistance |
| 06/01/2011 | EP2327784A2 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 06/01/2011 | EP2327783A1 Pharmaceutical composition comprising miRNA-100 and its use in the modulation of blood vessel growth |
| 06/01/2011 | EP2327782A1 Dna molecule for expressing haripin rna, the constructing method and the use thereof |